SunTrust Robinson Humphrey downgraded Bristol-Myers Squibb Co. (NYSE: BMY) from Buy to Neutral with a price target of $68.00 (from $86.00).

For an analyst ratings summary and ratings history on Bristol-Myers Squibb Co. click here. For more ratings news on Bristol-Myers Squibb Co. click here.

Shares of Bristol-Myers Squibb Co. closed at $75.32 yesterday.